Close menu




May 25th, 2022 | 11:46 CEST

Infineon, BrainChip, Daimler, Volkswagen - High-tech stocks at their best!

  • Electromobility
  • AI
  • Innovations
Photo credits: pixabay.com

The global automotive business is operating according to new laws. That is because e-mobility is a done deal, and if politicians' pronouncements are anything to go by, combustion engines will be history from 2030. As a result, the prerequisites for the industry are also changing because intelligent and powerful chips remain the basis for the further development of future mobility. Supply chains and Chinese reliability are still a problem, and high raw material prices will not make the new vehicles any cheaper. Innovations could be an effective means of combating the erosion of margins. Who is ahead in the market of high-tech players?

time to read: 4 minutes | Author: André Will-Laudien
ISIN: INFINEON TECH.AG NA O.N. | DE0006231004 , BRAINCHIP HOLDINGS LTD | AU000000BRN8 , DAIMLER AG NA O.N. | DE0007100000 , VOLKSWAGEN AG VZO O.N. | DE0007664039

Table of contents:


    Terry Lynch, CEO, Power Nickel
    "[...] Nickel, therefore, benefits twice: firstly from its growing importance within batteries and secondly from the generally growing demand for such storage. [...]" Terry Lynch, CEO, Power Nickel

    Full interview

     

    Infineon - Well positioned moving forward

    Demand at Infineon continues to be high, so the Munich-based technology group wants to equip itself for the future to continue to meet the expected boom in demand. Last fall, Infineon opened a new plant for power semiconductors in Villach, Austria. One of the mainstays of planning for the current fiscal year is the progress made in the important automotive division AVT. Infineon's chip business is still booming, and demand continues to outstrip supply significantly, which is likely to remain the case in the coming quarters. A super scenario would not be the restrictions on the supply side. Important components currently take an eternity until they are ready for further processing.

    Currently, the semiconductor manufacturer continues to benefit from the weak euro because since the takeover of the US competitor Cypress, around two-thirds of revenues are now invoiced in dollars. By the end of September, Infineon plans to achieve above-average growth, especially in its CSS division, which supplies chips for consumer electronics and credit cards. The EU wants to provide additional support for the semiconductor industry. Infineon could benefit from this directly through subsidies and indirectly through the expansion of value chains. Infineon expects sales of EUR 13 to 14 billion in the current fiscal year, and the segment profit margin is seen at more than 22%.

    The analysts at DZ Bank maintain their "buy" recommendation for Infineon shares. The price target remains unchanged at EUR 36. They expect Infineon to achieve earnings per share of EUR 1.84 in 2021/22. That puts the P/E ratio at 14.8, which is too low for the DAX share!

    BrainChip Holdings - Partnerships with Edge Impulse and ARM announced

    BrainChip Holdings is an Australian semiconductor company that manufactures a revolutionary neuromorphic processor called "Akida". The Akida processor can learn on its own while in use, as it improves the overall performance of artificial intelligence systems by reducing latency and power consumption. The new chip with AI capabilities represents a wide range of application areas, including control of autonomous vehicles, IoT devices and drones.

    BrainChip recently announced it is entering into a new partnership with Edge Impulse to develop next-generation machine learning platforms. Both companies aim to make BrainChip's neuromorphic technology, based on Spiking Neural Networks, widely applicable. It will involve combining the two partners' existing technologies to realize shorter development cycles. It is also expected to accelerate time-to-market in the future to gain a competitive advantage. Edge Impulse is a leader in edge AI development, and together with BrainChip, they plan to develop smart devices with AI/ML capabilities.

    And another highlight: with recent news, the Australians have been accepted into ARM's AI Partner Program, one of the biggest names in the chip sector. The British manufacturer's blueprints are the dominant standard for smartphones, tablets and mobile IoT devices. With the inclusion in the AI Partner Program of the market giant ARM, BrainChip has again succeeded in a super deal. It will allow the chipmaker to significantly expand the commercial reach of its Akida processors in the future.

    Technology company BrainChip Holdings has come under a lot of pressure since selling off on the NASDAQ. After rising to over EUR 1.60 in January, the share price fell back to EUR 0.65 by May, with a jump to EUR 0.88 at the beginning of the week. Should the correction on the NASDAQ be over, the BrainChip share will certainly be one of the high-flyers again.

    Mercedes versus Volkswagen - Who is ahead in e-mobility?

    The automotive industry relies on innovative solutions from Infineon and BrainChip. Those who equip their models with high technology at least have a modern buyer base behind them. Tomorrow's idea of mobility is characterized by autonomous driving, and primarily electric, of course. At least, that is how the broad consensus on the latest trends feels.

    At the moment, however, there are still reservations about electromobility and autonomous driving. Too few charging stations, too short a range and still uncontrollable situations make the AI-controlled vehicle react incorrectly. In the field of battery development, Stuttgart has already come a long way, as Mercedes recently presented an e-mobile called Vision EQXX that scores points for its high energy efficiency and allegedly manages up to 1,000 kilometers with one charging cycle.

    VW is promoting a future program and the new Group strategy 2030, "NEW AUTO - Mobility for Generations to Come". The Volkswagen Group and its 10 brands are thus paving the way for the biggest change process in its history: the realignment to become one of the world's leading providers of sustainable mobility. To this end, the Group will equip its core automotive business with more than 30 additional fully electric models by 2025 and accelerate the expansion of battery technology. Autonomous driving will be implemented as a new core competence. It sounds very futuristic already, in our opinion.

    In the race for investor favour, Mercedes shares clearly led the way over the past 12 months. It gained 4% compared to the VW share, which fell behind by a whopping 31%. It is not possible today to reliably predict who will achieve their goals faster. The fact is that both companies together account for just one-fifth of Tesla Motors. The Germans still have a long way to go to catch up, and in our opinion, the starting signal has already been given.


    The big stock market correction in 2022 has made many interesting high-tech stocks cheaper again. Without knowing where the "bottom" will ultimately be, one can already sum up: Infineon, Mercedes, Volkswagen, and BrainChip have all been badly hit. These shares will undoubtedly be among the top favourites again in the next upswing.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    André Will-Laudien

    Born in Munich, he first studied economics and graduated in business administration at the Ludwig-Maximilians-University in 1995. As he was involved with the stock market at a very early stage, he now has more than 30 years of experience in the capital markets.

    About the author



    Related comments:

    Commented by André Will-Laudien on April 24th, 2024 | 07:00 CEST

    Takeover rumors for biotech shares: BioNTech, Formycon, Cardiol Therapeutics and Novo Nordisk in focus

    • Biotechnology
    • Pharma
    • Innovations
    • Cancer

    The biotech sector has significantly lagged behind the performance of artificial intelligence and high-tech this year. This is due to high inflation, which in turn has made an imminent interest rate cut unlikely. Nevertheless, Germany's economic conditions are deteriorating dramatically, particularly due to the ongoing geopolitical conflicts. It should, therefore, come as no surprise if the ECB announces an "emergency interest rate cut" in the summer. That would then be the starting signal for a major reshuffle out of the best performers of recent months and into the long-neglected biotech segment. We have selected a few interesting stocks.

    Read

    Commented by André Will-Laudien on April 23rd, 2024 | 07:45 CEST

    Attention: DAX dividends! Car stocks pay out: Mercedes-Benz, MS Industrie, VW and BMW

    • Technology
    • hightech
    • Automotive
    • Electromobility

    The DAX 40 index has gone into reverse gear in recent weeks. In addition to the high-tech and artificial intelligence sectors, the multi-month bull market also included defense stocks in the interim phase. There is no real reason to celebrate among automotive stocks, as an expected decline in GDP also means reduced household budgets. This translates to fewer new vehicle sales, with many electric vehicles produced in bulk occupying important showroom space from dealers for months. The pain is increasing, and those looking to sell vehicles find themselves in ruinous discount battles with cheap Chinese imports. However, there appears to be a glimmer of hope on the horizon: interest rate cuts! They are expected in the second half of the year. We analyze the current situation.

    Read

    Commented by Fabian Lorenz on April 23rd, 2024 | 07:00 CEST

    TAKEOVER FEVER for biotech shares! Evotec, Bayer, Vidac Pharma - Who will follow Morphosys?

    • Biotechnology
    • Pharma
    • Innovations
    • Cancer

    There is takeover fever in the biotech sector. Genmab recently announced the acquisition of ProfoundBio, the US biotech company developing ovarian and endometrial cancer drugs, for USD 1.8 billion. With Morphosys, the takeover carousel is also turning in Germany. Who is the next candidate? Evotec is often mentioned. Due to unauthorized insider trading, the biotech company's shares have come under fire this year and offer an interesting entry opportunity. Vidac Pharma also impresses operationally. The Company's new approach has the potential to revolutionize cancer treatment. The study results of the past few months are very promising. Bayer shares surprised investors yesterday as one of the day's winners in the DAX. Is the Leverkusen-based company's stock about to take off?

    Read